The epidemiological findings are due to the requirement that a patient has previously been exposed to platelet-specific antigens before PTP can develop following a subsequent transfusion.
Blood is one of the oldest drugs in the world, but after many decades of research, it is still not always clear when a blood ...
Results: Three of 78 patients (4%) developed anti-D antibodies after receiving RhD-incompatible platelet transfusions. One of the patients developed evidence of anti-RhD antibodies after receiving ...